Items Tagged ‘Pancreatic Cancer’
August 1, 2023
2023 Gerstner Awardee’s ‘evolutionary therapy’ targets pancreatic cancer treatment resistance
By Susan Murphy 
Ryan Carr, M.D., Ph.D., a medical oncologist in Mayo Clinic’s Department of Oncology, is a recipient of the 2023 Gerstner Family Career Development Award. The competitive awards are presented annually by Mayo Clinic Center for Individualized Medicine to researchers conducting innovative investigations to predict, prevent, treat and cure diseases using individualized medicine approaches. Dr. Carr […]
Tags: Biomedical research, center for individualized medicine, Pancreatic Cancer
August 27, 2018
Gerstner awards boost research into hereditary cancer, Parkinson’s disease
Creating tools to detect cancer at an early stage and advancing research into the genetic links to Parkinson’s disease are focuses of the 2018 Gerstner Family Career Development Awards. This year’s winners are Niloy ‘Jewel’ Samadder, M.D., a gastroenterologist at Mayo’s Arizona campus whose research focuses on inherited cancer, and Fabienne Fiesel, Ph.D., a neurosciences […]
Tags: #Parkinson's disease, breast cancer, colon cancer, Dr. Niloy "Jewel" Samadder, Gertsner Family Career Development Awards, hereditary cancer, Mayo Clinic Center for Individualized Medicine, ovarian cancer, Pancreatic Cancer
June 19, 2018
Mayo Clinic discovers genetic links to pancreatic cancer
Pancreatic cancer is one of the most difficult forms of cancer to diagnose and treat. For many patients, the disease is not treatable through surgery and standard chemotherapy. New research published in JAMA, supported in part through the Mayo Clinic Center for Individualized Medicine, gives insight into the underlying genetic links to pancreatic cancer. Senior […]
Tags: #Dr. Fergus Couch, cancer genomics, Cancer Research, DNA Testing, Dr. Gloria Petersen, JAMA study, Mayo Clinic Cancer Center, Mayo Clinic Center for Individualize Medicine, Mayo Clinic Department of Laboratory Medicine and Pathology, Pancreatic Cancer
April 25, 2017
Energizing precision medicine researchers of the future
By Sharon Rosen
Engage. Inspire. Mentor. This is part of our mission at Mayo Clinic Center for Individualized Medicine. We want to energize and train future leaders in precision medicine research and patient care. That’s why our faculty joined other Mayo Clinic researchers in the Innovative Minds Partnering to Advance Curative Therapies (IMPACT) symposium held March 18 on […]
Tags: #Carolyn Rohrer Vitek, #Dr. Katherine Campbell, #IMPACT Symposium, #Northwestern Health Sciences University, center for individualized medicine, Dr. Matthew Ferber, individualized medicine, mayo clinic, Pancreatic Cancer
June 1, 2016
Researchers Identify Best Drug Therapy for Rare, Aggressive, Pancreatic Cancer
By Jeff Briggs
Genomic research and the application of individualized medicine are wide-spread throughout Mayo Clinic. The ability to collaborate in teams helps drive discovery, translation and application of medical breakthroughs. We are unrelenting in our search for new solutions. Right now, there are over 11,000 human studies under way across Mayo for devastating health conditions, and many […]
Tags: BRCA-2, center for individualized medicine, Dr. Gerardo Colon-Otero, Dr. Jason Hall, Dr. John Copland, genomic medicine, Genomic Research, mayo clinic, oxaliplatin, Pancreatic Cancer
January 22, 2016
Genomic Rearrangement Drives Pancreatic Cancer
By Jeff Briggs
Pancreatic cancer remains the fourth leading cause of cancer-associated deaths in the United States. While prognosis has improved for other major cancers thanks to early diagnosis, better therapies and a more comprehensive knowledge of genetic factors, death rates from pancreatic cancer continue to rise. Roughly 90 percent of pancreatic cancers are ductal pancreatic adenocarcinomas (PDAC) […]
Tags: biomarker, Biomarker Discovery Program, biomarkers, cancer, center for individualized medicine, Dr. George Vasmatzis, genomic medicine, NIH, Pancreatic Cancer
March 6, 2014
Who Inherits the Genomic Research Information of Deceased Participants?
Guest Post Written By: Jennifer McCormick, Ph.D. The discussions about what to do with incidental findings discovered during genetic and genomic research have recently taken on the question, “What do we do with clinically relevant incidental findings, when the research participant is deceased?” From a Bioethical standpoint, we need to examine what researchers should do, if […]
Tags: Biobank, Bioethics, Biorepositories, Biorepository, dna test, DNA Testing, gene sequencing, genome science, genomic medicine, Genomic Research, genomics, HIPAA